MOAT BIOTECHNOLOGY Corp — Form D

MOAT BIOTECHNOLOGY Corp of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-21. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Philip P JonesDirectorOklahoma City, OK
Russell P RotherDirectorSteamboat Springs, CO
Russell P RotherExecutive OfficerSteamboat Springs, CO
Russell P RotherPromoterSteamboat Springs, CO
Tetherex Pharmaceuticals P CorporationPromoterOklahoma City, OK
Michael P Moradi-AraghiDirectorOklahoma City, OK
Scott A RollinsDirectorOklahoma City, OK
Scott A RollinsExecutive OfficerOklahoma City, OK
Scott A RollinsPromoterOklahoma City, OK
Todd P FoleyDirectorAlta, WY
Phillip P JonesDirectorNorman, OK
Todd FoleyDirectorSouth San Francisco, CA
Philip A JonesDirectorOklahoma City, OK
Richard A AlvarezExecutive OfficerOklahoma City, OK
Tetherex Pharmaceuticals A CorporationPromoterOklahoma City, OK
Russell A RotherDirectorOklahoma City, OK
Russell A RotherExecutive OfficerOklahoma City, OK
Russell A RotherPromoterOklahoma City, OK
Todd A FoleyDirectorOklahoma City, OK
Philip JonesDirectorOklahoma City, OK
Tetherex Pharmaceuticals CorporationPromoterOklahoma City, OK
Richard AlvarezExecutive OfficerPhoenix, AZ
Scott RollinsDirectorOklahoma City, OK
Scott RollinsExecutive OfficerOklahoma City, OK
Scott RollinsPromoterOklahoma City, OK

Other filings by this issuer (3)

FiledFormOfferingSold
2025-10-20D$15.6M$26K
2023-02-09D$20.0M$102K
2022-10-11D/A$1.5M$1.5M

More